Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 10.32% is 27% below its 2-year average of 14.17%, near the low end of its 2-year range (5.53%–22.96%).
19.99% above its 12-month average of 8.60%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-03-31): 7.24%.
GROSS MARGIN
10.32%
GROSS MARGIN AVG TTM
8.60%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+19.99%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-78.13%
vs the sector median at left
Cellyan Biotechnology Co., Ltd
Market Cap
$1.13M
Gross Margin
10.32%
TTM Avg
8.60%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.09M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.15M
Gross Margin
88.34%
TTM Avg
40.30%
3Y Avg
45.15%
5Y Avg
63.43%
Market Cap
$1.01M
Gross Margin
-1.87%
TTM Avg
-0.94%
3Y Avg
-0.47%
5Y Avg
-0.37%
Market Cap
$1.36M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$877747.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
16.67%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.13M | 10.32% | 8.60% | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | 13.74% | 16.67% | 17.59% | 25.81% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.15M | 88.34% | 40.30% | 45.15% | 63.43% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -1.87% | -0.94% | -0.47% | -0.37% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Decoy Therapeutics Inc. (DCOY)vs › | $877747.00 | 0.00% | 0.00% | 0.00% | 16.67% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $897948.00 | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
10.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 7.24% |
| 2025-09-30 | 13.04% |
| 2025-03-31 | 5.53% |
| 2024-09-30 | 17.18% |
| 2024-03-31 | 22.96% |
| 2023-09-30 | 19.06% |
